Cyhoeddiad
2023
- Zhuang, X. et al. 2023. Claudin-10 in the blood brain barrier function of cerebral endothelial cells and transendothelial invasion of breast cancer cells. Anticancer Research 43(9), pp. 3923-3934. (10.21873/anticanres.16580)
- Fang, Z. 2023. Implication of capillary morphogenesis gene 2 (CMG2)in the disease progression and peritoneal metastasis of pancreatic cancer. PhD Thesis, Cardiff University.
- Fang, Z., Zeng, J. J., Yang, Y., Ruge, F., Lane, J., Hargest, R. and Jiang, W. 2023. Expression of ALCAM in clinical colon cancer and relationship with patients' treatment responses. In Vivo 37(3), pp. 1117-1128. (10.21873/invivo.13187)
- Liu, M., Sui, L., Fang, Z., Jiang, W. G. and Ye, L. 2023. Aberrant expression of bone morphogenetic proteins in the disease progression and metastasis of breast cancer. Frontiers in Oncology 13, article number: 1166955. (10.3389/fonc.2023.1166955)
- Yang, Y. M. et al. 2023. Activated leukocyte cell adhesion molecule (alcam), a potential 'seed' and 'soil' receptor in the peritoneal metastasis of gastrointestinal cancers. International Journal of Molecular Sciences 24(1), article number: 876. (10.3390/ijms24010876)
2022
- Fang, Z. et al. 2022. Sex hormone-regulated CMG2 is involved in breast and prostate cancer progression. Cancer Genomics & Proteomics 19, pp. 703-710.
- Fang, Z. et al. 2022. Sex hormone-regulatedcmg2is involved in breast and prostate cancer progression. Cancer Genomics & Proteomics 19(6), pp. 703-710. (10.21873/cgp.20353)
- Fang, Z., Jiang, W. and Ye, L. 2022. P-235 Elevated protein tyrosine phosphatase kappa expression is associated with disease progression and poor prognosis of pancreatic cancer. Annals of Oncology 33(S4), pp. S332-S332. (10.1016/j.annonc.2022.04.325)
Erthyglau
- Zhuang, X. et al. 2023. Claudin-10 in the blood brain barrier function of cerebral endothelial cells and transendothelial invasion of breast cancer cells. Anticancer Research 43(9), pp. 3923-3934. (10.21873/anticanres.16580)
- Fang, Z., Zeng, J. J., Yang, Y., Ruge, F., Lane, J., Hargest, R. and Jiang, W. 2023. Expression of ALCAM in clinical colon cancer and relationship with patients' treatment responses. In Vivo 37(3), pp. 1117-1128. (10.21873/invivo.13187)
- Liu, M., Sui, L., Fang, Z., Jiang, W. G. and Ye, L. 2023. Aberrant expression of bone morphogenetic proteins in the disease progression and metastasis of breast cancer. Frontiers in Oncology 13, article number: 1166955. (10.3389/fonc.2023.1166955)
- Yang, Y. M. et al. 2023. Activated leukocyte cell adhesion molecule (alcam), a potential 'seed' and 'soil' receptor in the peritoneal metastasis of gastrointestinal cancers. International Journal of Molecular Sciences 24(1), article number: 876. (10.3390/ijms24010876)
- Fang, Z. et al. 2022. Sex hormone-regulated CMG2 is involved in breast and prostate cancer progression. Cancer Genomics & Proteomics 19, pp. 703-710.
- Fang, Z. et al. 2022. Sex hormone-regulatedcmg2is involved in breast and prostate cancer progression. Cancer Genomics & Proteomics 19(6), pp. 703-710. (10.21873/cgp.20353)
- Fang, Z., Jiang, W. and Ye, L. 2022. P-235 Elevated protein tyrosine phosphatase kappa expression is associated with disease progression and poor prognosis of pancreatic cancer. Annals of Oncology 33(S4), pp. S332-S332. (10.1016/j.annonc.2022.04.325)
Gosodiad
- Fang, Z. 2023. Implication of capillary morphogenesis gene 2 (CMG2)in the disease progression and peritoneal metastasis of pancreatic cancer. PhD Thesis, Cardiff University.